Azal Hmoody Jumaa

6PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 24, 2025
Antiproliferative Potential of Linagliptin-Rivaroxaban Mixture in Cervical Cancer: Mechanistic Insights into Targeting Mutant MAPK, RAS kinase Signal Protein.

Buthaina Jasim Yousif, Doaa Hassan Abd Alwahab, Haneen A Mohammed

|Jul 29, 2025
Impact of Esomeprazole, Ciprofloxacin and Their Combination on Cervical Cancer Cell Line Proliferation: A Focus on Heat Shock Protein 70 Modulation.

Solafa Rabi Salih, Kawakeb Najim Abdulla, Anas K Awn

|Jun 21, 2025
Synergistic Cytotoxic Impact of Linagliptin - Ciprofloxacin Combination on Cervical Cancer Cell Line: Insights into Targeting Heat Shock Protein 60.

Tiba Th Al-Mahdawi, Ali Muafaq Said, Istikrar M Hade

|Apr 30, 2025
Scrutiny of the Co-Cytotoxic Impact of Metformin-Omeprazole on the Cervical Cancer Cell Line and Their Aptitude to Target Heat Shock 60.

Rasha Kareem Khudhur, Yahiya Ibrahim Yahiya, Aqeela Hayder Majeed

|Mar 01, 2025
Clinical Investigation of IL-31, TOS and GSH in the Sera of Gastric Cancer Females Patients In Iraq.

Montadher Ali Mahdi, Azal Hmoody Jumaa, Yasser Jassim Dawood

|Dec 29, 2023
Effect of Laetrile Vinblastine Combination on the Proliferation of the Hela Cancer Cell Line.

Youssef Shakuri Yasin, Azal Hamoody Jumaa, Shilan Jabbar

Pageof 1

Frequent Collaborators

4 joint publications

Youssef Shakuri Yasin

1 joint publications

Yahiya Ibrahim Yahiya

1 joint publications

Aqeela Hayder Majeed

1 joint publications

Tiba Th Al-Mahdawi